« "King of Torts" Pleads Guilty To Fraud | Main | A PR Take on Egilman & Zyprexa & the NYT »
September 26, 2007
NEJM Clears (Mostly) Thimerosol
In what is a relatively uncommon event in the last few years, the New England Journal of Medicine has good news this week for pharma, or at least vaccine manufacturers. A new study published there largely clears the the mercury in thimerosol in vaccines from causing autism:
Our study does not support a causal association between early exposure to mercury from thimerosal-containing vaccines and immune globulins and deficits in neuropsychological functioning at the age of 7 to 10 years.
--BC
September 26, 2007 in Products Liability | Permalink
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341bfae553ef00e54eeab5af8833
Listed below are links to weblogs that reference NEJM Clears (Mostly) Thimerosol:
